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ABSTRACT  
Objective: To assess the effect of methotrexate and omega-3 combination on cytogenetic changes of bone marrow and 
activities of some enzymatic antioxidants. 
Methods: Fifty-six mature male Wistar rats were divided into two experimental groups and a control group. The first 
experimental group was sub-divided into three sub-groups depending on the concentration of methotrexate (MTX): 
X1 (0.05 mg/kg MTX), X2 (0.125 mg/kg MTX) and X3 (0.250 mg/kg MTX), which were given intraperitoneally on a 
weekly basis for eight weeks. The second experimental group (MTX and omega-3 group) was also sub-divided into 
three sub-groups (Y1, Y2 and Y3), which were injected intraperitoneally with 0.05, 0.125 and 0.25 mg/kg MTX, respec-
tively, weekly for eight weeks accompanied by the oral administration of 300 mg/kg omega-3. The rats of the control 
group were given distilled water. The enzymatic activity of catalase (CAT), superoxide dismutase (SOD) and glutathi-
one reductase (GR) were measured in the sera of rats. In addition, the mitotic index (MI) and chromosomal aberra-
tions of bone marrow were also studied. 
Results: MTX resulted in a significant decrease in the activities of CAT, SOD and GR compared to the controls. It also 
increased the MI and chromosomal aberrations of rat bone marrows. On the other hand, omega-3 significantly in-
creased the activities of the investigated enzymatic antioxidants and reduced the MI and chromosomal aberrations in 
treated mice when given in combination with MTX. 
Conclusions: MTX has a genotoxic effect on the bone marrow by increasing the MI and all types of chromosomal aber-
rations and decreasing the enzymatic activity of CAT, SOD and GR. The addition of omega-3 can lead to a protective ef-
fect by reducing the toxic and mutagenic effects of MTX.  
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Methotrexate (MTX) is a folic acid antagonist be-
cause of their chemical similarity (1). Vezmar et 
al. (2) showed that MTX affects the synthesis of 
nucleic acids deoxyribonucleic acid (DNA) and 
ribonucleic acid (RNA) by interfering with the 
biosynthesis of thymine and purines. It also di-
rectly affects the rapidly dividing and intact cells, 
especially those in the mucous membranes of the 
mouth, intestine and bone marrow (3). 
Omega-3 is a type of unsaturated fats, which 
are classified as essential fatty acids that cannot 
be manufactured by the body and should be tak-
en with food (4). Sources of omega-3 include fish 
oils, such as salmon, sardines and tuna, as well as 
soybeans, walnuts, raisins and linseed, almonds 
and olive oils (5). Omega-3 is used in the preven-
tion of a number of diseases such as rheumatoid 
arthritis, ulcerative colitis, asthma, atherosclero-
sis, cancer, and cardiovascular diseases (6). A 
large amount of evidence indicates that omega-3 
fatty acids have significant health benefits, in-
cluding anti-inflammatory and antioxidant prop-
erties besides their effect on blood cholesterol 
levels (7). Antioxidants retard the oxidation pro-
cess by different mechanisms such as the remov-
al of free radicals (8).  
Enzymatic antioxidants include catalase 
(CAT), which is the first line of defense in the cell 
that removes hydrogen peroxide formed during 
biological processes by converting it into an al-
dehyde, and superoxide dismutase (SOD). There 
are three major families of SOD enzymes: man-
ganese SOD (Mn-SOD) in the mitochondria and 
peroxisomes, iron SOD (Fe-SOD) in prokaryote 
cells and copper/zinc SOD (Cu-Zn SOD) in the cy-
toplasm of eukaryote cells (9). Therefore, chang-
es in the metal co-factors (manganese, iron, cop-
per and zinc) can alter the effectiveness of SOD 
and may lead to diseases as a result of oxidative 
stress (10). Glutathione reductase (GR) 
is also an enzymatic antioxidant that converts 
the oxidized glutathione to the reduced glutathi-
one in the presence of NADPH, which is oxidized 
to NADP (11). Therefore, the aim of the present 
study was to assess the effects of MTX and ome-
ga-3 on the cytogenetic changes of bone marrow 
as well as the activities of CAT, SOD and GR en-
zymatic antioxidants in male rats. 
2. Methods 
2.1. Laboratory animals and experimental de-
sign  
Fifty-six mature male Wistar rats (Rattus 
norvegicus), aged 10–12 weeks old and weighing 
250–300 gm, were used in the present study. The 
rats were kept in separate cages, with natural 
13- hour light and 11-hour dark periods in a con-
tamination-free environment with a controlled 
temperature (28.0 ± 1.0°C). In addition, rats 
were maintained on a standard diet and tap wa-
ter ad libitum. 
The rats were randomly allocated to two ex-
perimental groups and a control group. The first 
experimental group (MTX group) included 24 
rats injected intraperitoneally with different 
MTX dilutions with distilled water (12). It was 
sub-divided into three sub-groups (eight rats per 
sub-group) according to MTX concentration as 
follows: X1 (0.05 mg/kg MTX), X2 (0.125mg/kg 
MTX) and X3 (0.25 mg/kg MTX). All rats were 
given a single dose of the specified MTX concen-
tration weekly for eight weeks. The second ex-
perimental group (MTX and omega-3 group) in-
cluded 24 rats allocated to three sub-groups (Y1, 
Y2 and Y3), which were injected intraperitone-
ally with 0.05, 0.125 and 0.25 mg/kg MTX, re-
spectively, weekly for eight weeks accompanied 
by the oral administration of 300 mg/kg omega-
3. The control group included eight rats that 
were intraperitoneally injected with distilled wa-
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ter and given a single dose of distilled water oral-
ly weekly for eight weeks. 
2.2. Blood collection and processing 
After the end of the dosing period, 5 ml of blood 
were withdrawn from the heart (by cardiac 
puncture) using a 5 cc disposable syringe. The 
collected blood was immediately poured into a 
clean sterile screw-capped tube (plain tube) and 
left for coagulation in a water bath at 37°C for 15 
minutes. After coagulation of blood, the plain 
tube was centrifuged for 5 minutes at 1500 rpm. 
Then the samples were stored at -20°C for sub-
sequent analysis. 
2.3. Measurement of the activity of antioxidant 
enzymes 
The antioxidant activities of CAT, SOD and GR 
were measured using enzyme-linked immuno-
sorbent assay kits purchased from Kamiya Bio-
medical Company (Seattle, WA, US), according to 
the manufacturer's instructions. 
2.4. Cytogenetic study of bone marrow 
Rats were killed by cervical dislocation, and their 
hip bones were cleaned from surrounding mus-
cles and then dissected by cutting both ends of 
the bone. Five milliliters of physiological buff-
ered saline were injected inside the bone to 
withdraw bone marrow into a test tube. Tubes 
were centrifuged at 2000 rpm/10 minutes. The 
supernatant was then removed, and 10 ml of KCL 
solution (0.075 M) were added to the sediment. 
The mixture was then incubated at 37 °C in a wa-
ter bath for 30 minutes, with shaking from time 
to time. The tubes were then centrifuged at 
2000rpm/10 minutes to remove the superna-
tant. However, 5 ml of a freshly prepared fixative 
solution (methanol: glacial acetic acid 1:3) were 
added gradually in the form of droplets into the 
inner wall of the tube with constant mixing. After 
that, the tubes were placed at 4 °C for half an 
hour to fix the cells. This process was repeated 
for three times, and the cells were then suspend-
ed in 2 ml of the fixative solution. The tubes were 
centrifuged at 2000 rpm for 5 minutes, and the 
supernatant was then removed while the cells 
were re-suspended in 1-2 ml of cold fixative solu-
tion. After shaking the tubes, 4–5 drops were 
then taken from each tube onto a clean slide 
from a height of about three feet to provide an 
opportunity for the cells and nuclei to spread 
well.  
The slides were stained with acridine orange 
solution (0.01%) for 4–5 minutes, incubated in 
Sorensen’s buffer (0.06M, pH 6.5) for a minute. 
and then examined using a fluorescence micro-
scope Olympus BX 51 America at a wavelength of 
450–500 nm (13, 14).  
A total of 1000 cells were examined, and both 
dividing and non-dividing cells were calculated 
(13). Mitotic index (MI) was calculated according 
to the following formula (13): MI= No. of dividing 
cells / 1000 × 100 
2.5. Analysis of chromosomal aberrations of 
bone marrow cells 
A total of 1000 dividing cells were examined on 
the stained slides under a fluorescence micro-
scope at a wavelength of 45–500 nm. The exam-
ined cells were at the first metaphase of the mi-
totic division, where chromosomal aberrations 
are clear and can be easily seen (13). 
 
2.6. Statistical analysis 
Data were analyzed using the Statistical Analysis 
System (SAS®) software, version 9.1 (Cary, NC, 
USA) (15). Effects were expressed as mean ± 
standard error (SE) and statistically compared 
using a completely randomized design analysis 
of variance and least significant differences. Dif-
ferences at P values <5 were considered statisti-
cally significant. 
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3.1. Effects of MTX and MTX-omega-3 combi-
nation on antioxidant enzymatic activities 
Table (1) shows significantly lower SOD activi-
ties among rats treated with MTX or MTX-
omega-3 compared to controls. Moreover, sera of 
rats receiving relatively high doses of MTX (sub-
groups X2 and X3) showed the lowest enzymatic 
activities of 4.29 ± 0.01 IU and 3.93 ± 0.11 IU, re-
spectively. On the other hand, CAT activity dif-
fered significantly between treated and control 
rats as well as among treated rats themselves, In 
this respect, the controls showed the highest ac-
tivity of 39.38 ±0.02 IU, while those receiving the 
highest MTX concentration, either alone or in 
combination with omega-3 (sub-groups X3 and 
Y3), showed the lowest activities of 30.97 ± 0.03 
IU and 32.12 ±  0.06 IU, respectively.  
Regarding GR activity, control rats showed a 
higher activity of 53.09 ±  0.05 IU compared to 
treated ones; however, the differences in GR ac-
tivities in rats given low doses of MTX, either 
alone or in combination with omega-3 (sub-
groups X1 and Y1), were not statistically signifi-
cant. On the other hand, rats in sub-groups X3 
and Y3 showed the lowest GR activities of 34.59 
± 0.63 IU and 37.15  ± 0.01, respectively, with sta-
tistically significant differences from other sub-
groups. 
3.2. Effects of MTX and MTX-omega-3 combi-
nation on mitotic index of bone marrow cells 
Figure (1) shows a significant decrease in the MI 
in all treated groups compared to control. In ad-
dition, there was a reverse association between 
MTX concentration and MI, where rats treated 
with the highest dose of MTX (sub-group X3) 
showed a significant decrease in MI compared to 
all other treated rat sub-groups. In addition, rats 
in sub-groups treated with MTX and omega-3 
(sub-groups Y1, Y2 and Y3) showed a significant 
increase in MI compared to their counterpart 
rats receiving MTX only. 
Table 1. Activity of antioxidant enzymes in rats treat-
ed with MTX and MTX-omega-3  
Group 
Enzymatic activity (mean ± SE) 
SOD (IU) CAT (IU) GR (µmol) 
Control 6.41±0.02 a 39.38±0.02 a 53.09±0.05 a 
X1 
(0.05 mg MTX/ kg) 
5.33±0.01 b 37.81±0.01 c 51.12±0.06 a 
Y1 
(0.05 mg MTX + 300 
mg omega-3/ kg) 
6.08±0.04 a 38.40±0.02 b 51.97±0.03 a 
X2 
(0.125 mg MTX/ kg) 
4.29±0.01 cd 33.13±0.01 e 42.34±0.03 b 
Y2 
(0.125 mg MTX + 
300 mg omega-3/ 
kg) 
4.99±0.40 b 36.68±0.02 d 43.02±3.04 b 
X3 
(0.25 mg MTX/ kg) 
3.93±0.11 d 30.97±0.03 g 34.59±0.63 c 
Y3 
(0.25 mg MTX + 300 
mg omega-3/ kg) 
4.47±0.02 c 32.12±0.06 f 37.15±0.01 c 
SE, Standard error; IU, international unit; SOD, superoxide 
dismutase; CAT, catalase; GR, glutathione reductase; 
*statistically significant at P < 0.05;  **statistically signifi-
cant at P < 0.01. Means with different letters within the 
same column showed a statistically significant difference. 
3.3. Effects of MTX and MTX-omega-3 combi-
nation on chromosomal aberrations of bone 
marrow cells 
Rats receiving higher concentrations of MTX 
(sub-group X3) showed a significant increase in 
all types of chromosomal aberrations, i.e., chro-
matid gaps, chromosome gaps, chromatid breaks, 
chromosome breaks, deletions and simple frag-
ments (Figure 2 and Table 2) than those of the 
control group or other treated sub-groups. All 
rats treated with MTX-omega-3 combination 
showed a significant decrease in almost all types 
of chromosomal aberrations compared to their 
counterpart rats receiving MTX alone (Table 2). 
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Figure 1. Effect of MTX and MTX-omega-3 on the MI of bone mar-
row cells of treated rats compared to the controls. The groups X1 
(0.05 MTX), X2 (0.125 MTX) and X3 (0.250 MTX) were compared to 
the control group, while the groups Y1 (0.05 MTX+ omega-3), Y2 
(0.125 MTX+ omega-3) and Y3 (0.25 MTX+ omega-3) were com-
pared to X1, X2 and X3, respectively. 
 
Figure 2. Effect of MTX and MTX-omega-3 on chromosomal aberra-
tion as seen under fluorescence microscope after staining with acri-
dine orange: (1) a simple fragment; (2) a chromatid gap; (3) a chro-
mosomal gap (A) and a chromosomal break (B). 
 
4. Discussion 
The present experiment reveals that the addition 
of omega-3 to MTX alleviates its effects on the ac-
tivities of the antioxidant enzymes CAT, SOD and 
GR, and decreases the MI as well as all types of 
chromosomal aberrations in the bone marrow 
cells. Daham et al. (16) showed that the decline 
in antioxidants associated with chemotherapy is 
attributed to the increase in lipid peroxidation 
caused by these kinds of drugs, which increase 
the level of free radicals. In addition, Weijl et al. 
(17) showed that some chemotherapeutic drugs 
have a negative effect on the antioxidant levels 
such as GR, whose activity decreases as a result 
of its involvement in many cellular processes 
such as cell defenses against the toxicity of some 
compounds. Al-Dalawy et al. (18) found that the 
decrease in the level of SOD is an evidence of its 
increased activity due to the increased release of 
free radicals. 
MTX causes an increase in the release of free 
radicals, including the OH radical that causes di-
rect damage to DNA (16). Al-Helaly (19) showed 
that the amount of food taken has an effect on 
antioxidants, where nutritional deficiency de-
creases the antioxidant levels, thus increasing 
free radicals that cause damage to DNA. 
 
Table 2. Chromosomal aberrations of bone marrow cells in rats treated with MTX and MTX-omega-3 
Group 






















Control 1.33±0.33 e 0.00±0.00 e 1.67±0.33 c 0.33±0.15 c 0.00±0.00 0.67±0.33 cd 0.04±0.005 f 
X1 2.75±0.47 cd 1.50±0.28 cd 2.50±0.64 bc 1.00±0.41 bc 0.50±0.28 bc 0.75±0.25 bcd 0.09±0.02 de 
Y1 1.75±0.47 de 0.75±0.25 de 1.50±0.28 c 1.00±0.00 bc 0.75±0.25 abc 0.75±0.25 abc 0.065±0.005 ef 
X2 4.67±0.33 b 2.67±0.33 ab 2.67±0.33 bc 1.67±0.33 ab 0.67±0.33 abc 1.67±0.33 ab 0.14±0.006 bc 
Y2 3.00±0.00 c 2.00±0.00 bc 3.00±0.057 bc 1.33±0.33 b 0.67±0.33 abc 0.33±0.15 d 0.106±0.003 cd 
X3 6.80±0.37 a 3.00±0.31 a 4.60±0.74 a 2.40±0.24 a 1.40±0.24 a 1.80±0.37 a 0.20±0.017 a 
Y3 5.60±0.40 ab 2.40±0.24 ab 3.60±0.24 ab 1.80±0.20 ab 1.20±0.20 ab 1.40±0.24 abc 0.16±0.003 b 
LSD 1.231** 0.814** 0.602** 0.841** 0.774* 0.941** 3.499* 
SE, Standard error; * statistically significant at P < 0.05;  ** statistically significant at P < 0.01. Means with different letters within the 
same column showed a statistically significant difference. X1 (0.05 mg MTX/ kg); X2 (0.125 mg MTX/ kg); X3 (0.25 mg MTX/ kg); Y1 
(0.05 mg MTX + 300 mg omega-3/ kg); Y2 (0.125 mg MTX + 300 mg omega-3/ kg); Y3 (0.25 mg MTX + 300 mg omega-3/ kg).  
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In the present study, the intraperitoneal ad-
ministration of MTX to rats also caused a de-
crease in the MI of bone marrow and a significant 
increase in the rate of abnormal chromosomal 
aberration compared to the control rats. This 
finding is consistent with those reported previ-
ously (20, 21). The effect of MTX can be attribut-
ed to its ability to interfere with the genetic ma-
terial, leading to the appearance of toxic and mu-
tagenic consequences. Rushworth et al. (22) re-
ported that MTX leads to a lack of dihydrofolate 
reductase, which is the key to the growth and cell 
division processes. This, in turn, leads to a reduc-
tion of the nucleotides involved in the building of 
DNA and, therefore, to a stop or obstruction of 
the repair mechanisms of the damaged DNA. In 
addition, Wong and Choi (23) concluded that 
MTX inhibits the action of enzymes controlling 
the purine metabolism, which leads to the accu-
mulation of adenosine in addition to the damage 
of the molecule itself and to the occurrence of 
chromosomal aberrations.  
Jafer et al. (24) reported the ability of MTX to 
induce chromosomal aberration in humans or 
animals by preventing the repair of DNA and af-
fecting the proteins found in chromosomes. The-
se findings were also confirmed by Hussain et al. 
(25), who found that MTX causes an increase in 
chromosomal aberrations. In the present study, 
the MI showed a significant increase in rat sub-
groups treated with MTX-omega-3 combination, 
but there was a decrease in the rate of chromo-
somal aberration, which confirms the role of 
omega-3 unsaturated fatty acids in protecting the 
cell from the impact of free radicals (26, 27). At-
tia and Nasr (28) reported the antioxidant effect 
of omega-3, which was attributed to the reduc-
tion in lipid peroxidation and the increase in SOD 
and CAT or the stimulation of GR. It is notewor-
thy that GR leads to the synthesis of reduced glu-
tathione, which is important in the defense of the  
 
cell against toxic substances and the prevention 
of the occurrence of mutations (29). 
5. Conclusions  
MTX significantly decreases the activity of enzy-
matic antioxidants, reduce the MI and increase 
the chromosomal aberrations of all types in bone 
marrow. This gives further evidence on the geno-
toxic effects of MTX on the bone marrow. On the 
other hand, omega-3 shows a protective effect by 
reducing the toxic and mutagenic effects of MTX.  
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